Hormonal Circadian Rhythms in Patients with Congenital Adrenal Hyperplasia: Identifying Optimal Monitoring Times and Novel Disease Biomarkers

OBJECTIVES: The treatment goal in congenital adrenal hyperplasia (CAH) is to replace glucocorticoids while avoiding androgen excess and iatrogenic Cushing’s syndrome. However, there is no consensus on how to monitor disease control. Our main objectives were to evaluate hormonal circadian rhythms and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Endocrinol
Autors principals: Debono, Miguel, Mallappa, Ashwini, Gounden, Verena, Nella, Aikaterini A, Harrison, Robert F, Crutchfield, Christopher A, Backlund, Peter S, Soldin, Steven J, Ross, Richard J, Merke, Deborah P
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623929/
https://ncbi.nlm.nih.gov/pubmed/26340969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-15-0064
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars